Merit Medical Systems, Inc.

Merit Medical Systems designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures globally. Its business is organized into two segments: Cardiovascular and Endoscopy. The Cardiovascular segment offers products such as micropuncture kits, angiographic needles, sheaths, guide wires, safety products, peripheral intervention products (angiography, drainage, delivery systems, embolotherapy), oncology products (soft tissue biopsy products and accessories), cardiac intervention products (cardiac access, angiography, electrophysiology, fluid management, hemodynamic monitoring, hemostasis), spine products (vertebral augmentation, radiofrequency ablation, bone biopsy systems), and custom procedural solutions (critical care products, syringes, manifold kits, trays and packs). The Endoscopy segment provides gastroenterology products (esophageal stents, cryoballoon and inflation devices, gauges, balloon dilators) and pulmonary products (laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, kits and accessories for endoscopy and bronchoscopy procedures).

Merit Medical Systems is listed on the NasdaqGS exchange under the ticker symbol MMSI. The company is based in the United States and trades in US Dollars (USD). As a Nasdaq-listed stock, it is subject to the reporting and regulatory requirements of the US Securities and Exchange Commission. Investors can trade MMSI shares during regular Nasdaq trading hours, and the stock is denominated in USD, making it accessible primarily to investors using US currency.

Merit Medical Systems operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This industry includes companies that manufacture and distribute medical devices, instruments, and supplies used in healthcare settings. As a medical instruments and supplies company, Merit Medical focuses on single-use products for interventional, diagnostic, and therapeutic procedures. Its products are used by hospitals and alternate site-based physicians, technicians, and nurses. The company's portfolio spans cardiovascular and endoscopy applications, including items like guide wires, stents, biopsy systems, and custom procedural kits.

Merit Medical Systems is headquartered in the United States and serves a global market. The company distributes its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales. Its products are used in interventional, diagnostic, and therapeutic procedures worldwide. The company's global reach is supported by its two business segments: Cardiovascular and Endoscopy, which offer a wide range of single-use medical products. While the company is based in the US, its products are designed to meet the needs of healthcare providers internationally, making it a player in the global medical devices market.

Merit Medical Systems generates revenue by designing, manufacturing, and selling single-use medical products used in interventional, diagnostic, and therapeutic procedures. The company's revenue is derived from two segments: Cardiovascular and Endoscopy. The Cardiovascular segment includes products like micropuncture kits, angiographic needles, guide wires, peripheral intervention products, oncology biopsy products, cardiac intervention devices, spine products, and custom procedural solutions. The Endoscopy segment offers gastroenterology products such as esophageal stents and cryoballoon devices, as well as pulmonary products like tracheobronchial stents and delivery systems. Products are sold directly to hospitals and alternate site-based healthcare professionals. The company also provides coating services for medical tubes and wires and sensor components for microelectromechanical systems, adding additional revenue streams.